ArticleCancer research2010

Combining CD19 redirection and alloanergization to generate tumor-specific human T cells for allogeneic cell therapy of B-cell malignancies.

Jeff K Davies et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.